Both MAGA World and liberals have turned on Musk’s Tesla as Trump divorce turns friends to foe Trump-Musk feud live updates: ...

Throughout 2024, many of the tech industry’s boldfaced names threw their support and hundreds of millions ... also endorsed ...

When times get tough, corporate CEOs collapse like cowards. Make America Great Again types are opposing Pride parades ...

Elon Musk’s fortune shrank by $33.9 billion overnight on 6 June 2025, following a dramatic 14 per cent plunge in Tesla shares—amid escalating tensions with Donald Trump and investor anxiety over ...

Elon Musk's net worth fell by $33.9 billion to $335 billion after Tesla's 14% share drop on June 6, 2025, which wiped out ...

As Meta Platforms shifts focus and rides a bullish trend, investors should formulate a strategy for all likely outcomes. 24/7 ...

Hardware stocks like chipmaker Nvidia Corp. (ticker: NVDA) or Taiwan Semiconductor Manufacturing Co. Ltd. (TSM) tend to be the first stop for investors looking to play the artificial ...

Bluesky is a fast-growing Twitter rival, with 36 million users. CEO Jay Graber explains its origin, and future plans, in a ...

Daniel Lurie enlists business titans and his wealthy friends to pull the tech hub out of its post-Covid slump — and restore ...

Fake stuff in a newspaper is deadly. You don’t get many second chances to prove your worth to the public when facts are your ...

Amid Business Insider's latest pivot to AI, the site's past brushes with the technology are coming back to haunt it.

BioNTech and Bristol Myers Squibb have agreed to jointly develop and commercialize BioNTech's BNT327 cancer-drug candidate in a deal potentially worth more than $11 billion to the German drugmaker.